STOCK TITAN

Inspira Technologies Oxy B.H.N. Ltd. (IINN) Financials

IINN NASDAQ

Ticker history: IINN became QTEX (QTREX Quantum Ltd.) on .

FY2025 annual
Revenue $289K n/m YoY
Net Income -$13.2M n/m YoY
EPS (Diluted) -$0.45 YoY not available
Free Cash Flow -$10.0M n/m YoY
Source SEC Filings (20-F/6-K) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD FYE December

Newest figures come from the 20-F for FY2025, filed Mar 26, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the IINN SEC filings page.

Inspira Technologies Oxy B.H.N. Ltd. (IINN) reported $289K in revenue for fiscal year 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (20-F and 6-K reports).

Rhea AI IINN FY2025

FY2025 shows a development-stage business whose research spending far exceeds sales, while operations remain funded partly through financing.

FY2025 operating cash flow was -$9.861M while free cash flow was -$9.964M, so capital expenditures were not the main source of cash pressure. With financing cash flow of $7.327M, the cash profile points to an investment-stage model funded partly outside operations rather than one whose losses are mainly caused by fixed-asset reinvestment.

Research spending dominates the current business model: R&D was $7.496M against revenue of $289K, so reported sales do not yet absorb the development base. The supplied R&D-to-revenue proportion was 2593.8%, reinforcing that FY2025 economics are driven by investment rather than commercial volume.

Balance-sheet flexibility has narrowed materially: the current ratio fell from 8.7x in FY2022 to 1.6x in FY2025, reducing short-term cushion. Liabilities rose from 15.7% of assets in FY2022 to 56.5% in FY2025, indicating that obligations occupy a larger share of a shrinking asset base.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

We do not publish a peer-relative financial health score for Inspira Technologies Oxy B.H.N. Ltd., because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.

Piotroski F-Score Partial
2/7

Inspira Technologies Oxy B.H.N. Ltd. passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), the one computable operating efficiency signal (asset turnover improving) passes.

Earnings Quality No Cash Backing
N/A

Inspira Technologies Oxy B.H.N. Ltd. reported a net loss of $13.2M while operations used $9.9M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$289K
YoYn/m

Inspira Technologies Oxy B.H.N. Ltd. generated $289K in revenue in fiscal year 2025. The change from the prior year is not meaningful, because that figure was zero or negative.

EBITDA
-$13.5M
YoYn/m

Inspira Technologies Oxy B.H.N. Ltd.'s EBITDA was -$13.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. The change from the prior year is not meaningful, because that figure was zero or negative.

Net Income
-$13.2M
YoYn/m

Inspira Technologies Oxy B.H.N. Ltd. reported a net loss of $13.2M in fiscal year 2025. The change from the prior year is not meaningful, because that figure was zero or negative.

EPS (Diluted)
-$0.45

Inspira Technologies Oxy B.H.N. Ltd. earned -$0.45 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
-$10.0M
YoYn/m

Inspira Technologies Oxy B.H.N. Ltd. recorded an outflow of $10.0M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. The change from the prior year is not meaningful, because that figure was zero or negative.

Cash & Debt
$3.2M
YoY-38.2%

Inspira Technologies Oxy B.H.N. Ltd. held $3.2M in cash as of fiscal year 2025; no long-term debt figure is on record for that period.

Shares Outstanding
36M

Inspira Technologies Oxy B.H.N. Ltd. had 36M shares outstanding in fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
0.7%

Inspira Technologies Oxy B.H.N. Ltd.'s gross margin was 0.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs.

Return on Equity
-569.1%
YoY-313.4pp

Inspira Technologies Oxy B.H.N. Ltd.'s ROE was -569.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 313.4 percentage points from the prior year.

Operating Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending
$7.5M
YoY+18.6%

Inspira Technologies Oxy B.H.N. Ltd. invested $7.5M in research and development in fiscal year 2025. This represents an increase of 18.6% from the prior year.

Capital Expenditures
$103K
YoY-37.2%

Inspira Technologies Oxy B.H.N. Ltd. invested $103K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 37.2% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

IINN Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IINN annual income statement
MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-F
Revenue$289Kn/m$0n/m$0N/AN/A
Cost of Revenue$287Kn/m$0n/m$0N/AN/A
Gross Profit$2Kn/m$0n/m$0N/AN/A
R&D Expenses$7.5M+18.6%$6.3M-13.6%$7.3M-10.5%$8.2M+101.1%$4.1M
SG&A Expenses$5.5M+32.2%$4.2M+3.0%$4.1M-24.4%$5.4M-22.5%$6.9M
Operating Income-$13.6Mn/m-$11.3Mn/m-$12.1Mn/m-$14.9Mn/m-$13.0M
EBITDA-$13.5Mn/m-$11.1Mn/m-$12.0Mn/m-$14.8Mn/m-$12.9M
Interest ExpenseN/AN/A$1.2MN/AN/A
Income Tax$0n/m$0n/m$0N/AN/A
Net Income-$13.2Mn/m-$11.1Mn/m-$11.3Mn/m-$15.0Mn/m-$17.2M
EPS (Basic)-$0.45-$0.60-$0.93n/m-$1.39-$3.24
EPS (Diluted)-$0.45-$0.60-$0.93n/m-$1.39-$3.24
Diluted Shares (Avg)30M19M12M+12.1%11M5M

IINN Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IINN annual balance sheet
MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-F
Total Assets$5.3M-33.8%$8.1M-13.3%$9.3M-42.4%$16.2MN/A
Current Assets$4.4M-35.2%$6.8M-12.6%$7.8M-46.2%$14.5MN/A
Cash & Equivalents$3.2M-38.2%$5.1M+1.4%$5.0M-25.7%$6.8M-71.6%$23.9M
Short-Term Investments$0N/AN/AN/AN/A
Inventory$735K+65.5%$444KN/AN/AN/A
Long-Term Investments$0N/AN/AN/AN/A
Total Liabilities$3.0M-19.5%$3.7M+4.9%$3.6M+40.9%$2.5MN/A
Current Liabilities$2.8M-16.2%$3.4M+12.9%$3.0M+79.5%$1.7MN/A
Non-Current Liabilities$194K-48.7%$378K-35.7%$588K-32.6%$873KN/A
Total Equity$2.3M-46.3%$4.3M-24.7%$5.7M-57.9%$13.6M-42.6%$23.7M

Not reported in any period shown, so not listed: Accounts Receivable, Goodwill, Long-Term Debt, Retained Earnings.

IINN Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IINN annual cash flow statement
MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-F
Operating Cash Flow-$9.9Mn/m-$9.4Mn/m-$9.7Mn/m-$9.2Mn/m-$6.7M
Depreciation & Amortization$150K-12.3%$171K+54.1%$111K+105.6%$54K+116.0%$25K
Stock-Based Compensation$3.6M+89.0%$1.9M+32.6%$1.4M-70.8%$4.9M-27.2%$6.7M
Capital Expenditures$103K-37.2%$164K-20.4%$206K-21.7%$263K+44.5%$182K
Free Cash Flow-$10.0Mn/m-$9.5Mn/m-$9.9Mn/m-$9.5Mn/m-$6.9M
Investing Cash Flow$565K-62.0%$1.5M-67.6%$4.6Mn/m-$7.4Mn/m-$182K
Financing Cash Flow$7.3M-7.3%$7.9M+128.8%$3.5MN/A$30.2M

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

IINN Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

IINN annual financial ratios
MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-F
Gross Margin0.7%N/AN/AN/AN/A
Operating Margin-4713.8%N/AN/AN/AN/A
Net Margin-4574.4%N/AN/AN/AN/A
Return on Equity-569.1%-313.4pp-255.7%-59.0pp-196.7%-86.8pp-109.9%-37.4pp-72.5%
Return on Assets-247.5%-110.6pp-137.0%-15.7pp-121.2%-28.6pp-92.6%N/A
Current Ratio1.56-0.5x2.02-0.6x2.61-6.1x8.72N/A
Liabilities-to-Equity1.30+0.4x0.87+0.2x0.62+0.4x0.19N/A
Asset Turnover0.05+0.1x0.000.0x0.00N/AN/A
FCF Margin-3447.8%N/AN/AN/AN/A

Not reported in any period shown, so not listed: Debt-to-Equity.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Inspira Technologies Oxy B.H.N. Ltd. IINN FY2025 $289K -$13.2M N/A N/A —
Intelligent Bio Solutions Inc. INBS FY2026 $4.2M -$12.4M N/A $5.1M 40/100
WORK Medical Technology Group LTD WOK FY2025 $9.8M -$1.1M -10.9% $5.2M 27/100
Trinity Biotech plc TRIB FY2025 $43.8M -$37.4M -85.4% $4.7M 44/100
Inspire Medical Systems, Inc. INSP FY2025 $912.0M $145.4M 16.0% $1.7B 65/100
Standard BioTools Inc. LAB FY2025 $85.3M -$74.9M -87.8% $225.0M 46/100

Frequently Asked Questions

Inspira Technologies Oxy B.H.N. Ltd. (IINN) reported $289K in total revenue for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

No, Inspira Technologies Oxy B.H.N. Ltd. (IINN) reported a net loss of $13.2M in fiscal year 2025.

Inspira Technologies Oxy B.H.N. Ltd. (IINN) reported diluted earnings per share of -$0.45 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Inspira Technologies Oxy B.H.N. Ltd. (IINN) had EBITDA of -$13.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Inspira Technologies Oxy B.H.N. Ltd. (IINN) had a gross margin of 0.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Inspira Technologies Oxy B.H.N. Ltd. (IINN) has a return on equity of -569.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Inspira Technologies Oxy B.H.N. Ltd. (IINN) recorded an outflow of $10.0M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Inspira Technologies Oxy B.H.N. Ltd. (IINN) recorded an outflow of $9.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Inspira Technologies Oxy B.H.N. Ltd. (IINN) had $5.3M in total assets as of fiscal year 2025, including both current and long-term assets.

Inspira Technologies Oxy B.H.N. Ltd. (IINN) invested $103K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Inspira Technologies Oxy B.H.N. Ltd. (IINN) invested $7.5M in research and development during fiscal year 2025.

Inspira Technologies Oxy B.H.N. Ltd. (IINN) had 36M shares outstanding as of fiscal year 2025.

Inspira Technologies Oxy B.H.N. Ltd. (IINN) had a current ratio of 1.56 as of fiscal year 2025, which is generally considered healthy.

Inspira Technologies Oxy B.H.N. Ltd. (IINN) had a liabilities-to-equity ratio of 1.30 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.

Inspira Technologies Oxy B.H.N. Ltd. (IINN) had a return on assets of -247.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

At the end of fiscal year 2025, Inspira Technologies Oxy B.H.N. Ltd. (IINN) held $3.2M in cash, cash equivalents and investments, and reported an operating cash outflow of $9.9M over that year. Dividing the one by the other, the reported balance equals about 4 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Inspira Technologies Oxy B.H.N. Ltd. (IINN) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Inspira Technologies Oxy B.H.N. Ltd. (IINN) reported a net loss of $13.2M while operations used $9.9M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top